Video

The larger the "A," the more likely you are to pay the cost of negative dysphotopsia

Author(s):

Kassi Jackson
Conferences|ASCRS

Mark Packer, MD, discusses the causes, factors, and treatments of negative dysphotopsia.

Related Videos
Related Content
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Published: December 19th 2024 | Updated: December 19th 2024

Study validates long-term efficacy of MicroPulse TLT for glaucoma management

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Aurion Biotech announces topline results from Phase 1/2 trial of AURN001 for corneal edema
December 18th 2024

Aurion Biotech announces topline results from Phase 1/2 trial of AURN001 for corneal edema

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios
December 12th 2024

Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases
December 10th 2024

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases

© 2024 MJH Life Sciences

All rights reserved.